Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - VIROPHARMA INC | d10q.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - VIROPHARMA INC | dex311.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - VIROPHARMA INC | dex312.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of ViroPharma Incorporated (the “Company”) on Form 10-Q for the period ending June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Vincent J. Milano |
| Vincent J. Milano President and Chief Executive Officer July 28, 2010 |
| /s/ Charles A. Rowland, Jr. |
| Charles A. Rowland, Jr. Chief Financial Officer July 28, 2010 |